New research from the Spastic Paraplegia Centers of Excellence Research Network (SP-CERN). This summary is based on a paper published in the journal Brain on May 5, 2026, titled "Genotype–structure–phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4." 

Read the paper here. 

Learn more about SP-CERN. 

Transcript: 

Hereditary spastic paraplegia type 4 (SPG4) is the most common form of hereditary spastic paraplegia, a large group of inherited disorders that affect the long nerve pathways carrying movement signals from the brain down the spinal cord to the legs. SPG4 is caused by changes in the SPAST gene. People with SPG4 commonly experience difficulty walking due to muscle weakness and spasticity (muscle rigidity) in the legs, as well as hyperreflexia (overactive bodily reflexes), urinary urgency or bladder dysfunction, and mild loss of vibration sense in the feet. Symptoms and time of disease onset can be very different from person to person, even within the same family. Not much is known about the natural history of SPG4, making it difficult to conduct clinical trials and find new therapies. 

In this study, researchers investigated genotype–phenotype correlations and the natural history of early-onset SPG4. The team used deep phenotyping to analyze 206 patients with genetically confirmed SPG4 from seven international centers. Researchers also studied data from an additional 146 patients from previous studies.

Results provide the most detailed natural history of SPG4 to date, creating a framework that links specific genetic variants to different clinical trajectories. Authors note that these findings can improve care and optimize clinical trial design for SPG4.